Hepatitis C virus epidemiology and prevention in Polish and Swiss population – similar and contrasting experiences

Benjamin Sakem 1, Kazimierz Madaliński 2, Urs Nydegger 1, Małgorzata Stępień 3, Paulina Godzik 3, Agnieszka Kołakowska 3, Lorenz Risch 1, Martin Risch 1, Karolina Zakrzewska 4, Magdalena Rosińska 5
1 - Labormedizinisches Zentrum Dr. Risch, Liebefeld, Switzerland
2 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
3 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
4 - 1. National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland; 2.Department of Epidemiology, Medical University of Warsaw, Poland
5 - National Institute of Public Health – National Institute of Hygiene, Warsaw, Poland
Ann Agric Environ Med
2016; 23 (3):
ICID: 1219181
Article type: Original article
Objective. The aim of the study was to review available data on HCV in Poland and Switzerland, in order to compare the two European countries with respect to epidemiological situation and efficiency of the response systems.
Materials and method. A search of registries, published and grey literature was performed to assemble data on prevalence, rate of detection of new cases, identified risk factors for transmission, mortality due to HCV, prevalence of HCC and the consequent liver transplantations, as well as data on treatment in Poland and Switzerland.
Results. Overall, the prevalence of anti-HCV antibodies was similar, not exceeding 1%. However, the major transmission routes of HCV infections were different: medical procedures in Poland and drug injections in Switzerland. By combining the available information it was also possible to demonstrate important differences in efficiency of the response systems. There was approximately 1 new diagnosis per 100 estimated undiagnosed cases in the population in Poland per year, compared to 6 in Switzerland, and the treatment rate per 100 estimated active infections was 2 and 4, respectively.
Conclusions. Scaling up of the diagnosis and treatment is necessary in both countries; however, the means to achieve this might differ, taking into account the higher concentration of the infections in risk groups in Switzerland than in Poland.
DOI: 10.5604/12321966.1219181
PMID 27660862 - click here to show this article in PubMed

Recommend this article to:


Related articles in IndexCopernicus™
     access to treatment [1 related records]
     consequences of infection [0 related records]
     Poland and Switzerland [0 related records]
     epidemiological data [2 related records]
     acute and chronic HCV infection [0 related records]
     Hepatitis C [245 related records]


Related articles

G Subramanian,  Vegad,
 Seroprevalence of hepatitis C in renal failu...
 Background: Hepatitis C is endemic in most parts of the world. It is a blood borne infection, which has a significant impact in treatment and outcome of renal failure patients undergoing dialysis. Objective: To determine the seroprevalence of...
S Schaeffer, M Khalili,
Reasons for HCV non-treatment in underserved Afric...
Background. African Americans are disproportionately affected by hepatitis C (HCV) and are less likely to undergo HCV treatment. Underserved populations are especially at risk for experiencing health disparity. Aim. To identify reasons for HCV non-tr...
D Kliemann, F Wolff,
 Biochemical non-invasive assessment of liver...
 Background and rationale. The liver biopsy has been considered the gold standard for the diagnosis and quantification of fibrosis. However, this method presents limitations. In addition, the non-invasive evaluation of liver fibrosis is a challe...